BioLineRx Ltd. (TLV:BLRX)

Israel · Delayed Price · Currency is ILS · Price in ILA

1.100

0.00 (0.00%)

Oct 23, 2026, 1:44 PM IDT

BioLineRx Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	33	42	86	415	100	309
Market Cap Growth	-40.07%	-51.17%	-79.39%	314.57%	-67.59%	60.58%
Enterprise Value	26	-4	87	367	-65	126
Last Close Price	0.01	0.02	0.06	0.38	0.14	0.43

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	14.45	14.45	14.45	14.45	14.45
PS Ratio	7.92	11.10	0.81	24.01	-	-
PB Ratio	0.66	0.56	1.75	8.72	0.56	1.46
P/TBV Ratio	-	7.17	7.80	-	0.98	2.14

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	6.28	-	0.83	21.22	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.48	0.44	1.12	0.88	0.24	0.07
Net Debt / Equity Ratio	-0.31	-0.46	-0.34	-2.37	-0.76	-0.77
Net Debt / EBITDA Ratio	0.42	1.07	0.30	0.76	1.36	2.18
Net Debt / FCF Ratio	0.47	1.32	0.10	1.38	1.47	2.22
Asset Turnover	0.04	0.03	0.56	0.07	-	-
Inventory Turnover	0.11	0.09	3.63	-	-	-
Quick Ratio	1.01	1.76	1.52	1.02	4.85	5.89
Current Ratio	1.20	1.95	1.76	1.10	4.87	5.91
Return on Equity (ROE)	-55.27%	-11.01%	-69.11%	-189.23%	-41.96%	-60.04%
Return on Assets (ROA)	-19.82%	-16.11%	-23.28%	-38.30%	-23.10%	-24.07%
Return on Capital Employed (ROCE)	-61.50%	-35.70%	-81.50%	-203.40%	-44.40%	-34.60%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-71.42%	-8.97%	-39.26%	-52.59%	-87.63%	-27.24%
FCF Yield	-98.18%	-61.81%	-187.02%	-19.72%	-92.62%	-23.83%
Buyback Yield / Dilution	-49.34%	-105.76%	-24.37%	-24.47%	-16.75%	-162.19%